BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37568464)

  • 1. Prescribed Versus Taken Polypharmacy and Drug-Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study.
    Anfinogenova ND; Novikova OM; Trubacheva IA; Efimova EV; Chesalov NP; Ussov WY; Maksimova AS; Shelkovnikova TA; Ryumshina NI; Stepanov VA; Popov SV; Repin AN
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
    Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
    Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia.
    Assefa YA; Kedir A; Kahaliw W
    Integr Pharm Res Pract; 2020; 9():1-9. PubMed ID: 32021833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of potential drug-drug interactions in adults with intellectual disability.
    McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
    J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
    Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
    BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
    Sheikh-Taha M; Asmar M
    BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
    Semin Arthritis Rheum; 2024 May; 67():152469. PubMed ID: 38781783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
    Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
    Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Drug-Drug Interactions in Hospitalized Medical Patients: Data From Low Resource Settings.
    Rashid K; Khan Y; Ansar F; Waheed A; Aizaz M
    Cureus; 2021 Aug; 13(8):e17336. PubMed ID: 34557372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
    Straubhaar B; Krähenbühl S; Schlienger RG
    Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.
    Sutherland JJ; Morrison RD; McNaughton CD; Daly TM; Milne SB; Daniels JS; Ryan TP
    JAMA Netw Open; 2018 Nov; 1(7):e184196. PubMed ID: 30646345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are drug-drug interactions a real clinical concern?
    Das S; Behera SK; Xavier AS; Dharanipragada S; Selvarajan S
    Perspect Clin Res; 2019; 10(2):62-66. PubMed ID: 31008071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of comedications and potential drug-drug interactions in people living with HIV in China.
    Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
    J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases.
    Meakleartmongkol T; Tangpanithandee S; Vanavivit N; Jiso A; Pongchaikul P; Kirdlarp S; Khemawoot P; Nathisuwan S
    PLoS One; 2023; 18(11):e0293866. PubMed ID: 37972000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
    Courlet P; Livio F; Guidi M; Cavassini M; Battegay M; Stoeckle M; Buclin T; Alves Saldanha S; Csajka C; Marzolini C; Decosterd L;
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz531. PubMed ID: 31909082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.